# Trade Mark Journal No.2026/011 13 March 2026

## UK00004347756 2 March 2026 (42)

OPTIMISM

International priority date claimed: 10 October 2025 (United States of America) (99436273)

Class 42
  Scientific research in the nature of conducting clinical trials for others in the field of pharmaceuticals that treat systemic mastocytosis.

Telios Pharma Inc.

Representative: Morgan, Lewis & Bockius UK LLP